2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
The Global Business News Leader | Saturday, 11 Oct 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
TEVA PHARM INDS AD
TEVA (NASDAQ)
$ 38.49 
Change: -1.69 -4.39% | Volume: 16,643,992
Change: -1.69 -4.39% | Volume: 16,643,992
Sponsored by 
TEVA PHARM ADR - Fundamental Profile
Company Information
| Ticker Symbol: | TEVA |
|---|---|
| Exchange: | NASD |
| Contact Info: | 5 Basel Street Petach Tikva 49131 972-3-9267590 |
| CEO/President: | Israel Makov |
| Industry: | Medical - Generic Drugs / Standard Industry Code: 2834 |
| Description: | TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories. |
Share Information
| Shares Outstanding: | 812,000 (000) | Market Value: | 34,842,920 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 54.90% | Number of Inst.Shareholders: | 7.10% |
| Last Quarter Sales: | 2823.00 ($Mil.) | Last Quarter Net Income: | 539.00 ($Mil.) |
| Last Quarter EPS: | 0.65 | P/E Ratio: | 16 |
| Most Recent Earnings: | 0.64 on 05/06/08 | Earnings Per Share: | 2.16 |
| Most Recent Split: | 2-1 on 07/01/04 | Annual Dividend Rate: | .51 |
| Most Recent Dividend: | 0.104 on 08/01/08 | Annual Dividend Yield: | 1.19% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
TEVA
Companies
IBT
- Ahead of the Bell: Generic drug makers
- Teva and Kowa to create Japanese generic maker
- Obama, McCain advisers agree...on generic drugs
- Citi names Lehman exec to run merger department
- Movers roundup: F5 Networks, Wachovia
- More consolidation seen in generic drug industry
- Indevus shares double on deals with FDA, Teva
- AIG Units Party, Luxury Resort Conference Upsets Watchdogs
- Ahead of the Bell: Morgan Stanley plunges
- Gold bullion and stocks shine during one of most volatile days
- Harley revs up cooler image with supermodel Miller
- Morgan Stanley shares sink on worries about future
- SEC head asks for reins on credit default swaps
- Fed slashes interest rates, but stocks lose again
- Brad Pitts exclusive photos of Angelina Jolie breastfeeding appears on W Magazine Cover
- W Magazine Angelina Jolie: I bought Maddox his first knife
- Sarah Palin is Princess Dianas and Roosevelts distant cousin
- Angelina Jolie: My Twins Are Totally Sweet
- Ahead of Troopergate Report, NYT Says Official Pressured Indirectly
- Playboy Hugh Hefner New Girlfriends: Karissa and Kristina Shannon, Amy Leigh Andrews
- PHOTO: W Magazine cover shows Angelina Jolie breastfeeding
Top Competitors
| MYLAN INC |  |
-53.90 | 7.22 |
| TEVA PHARM INDS | |
-21.00 | 38.49 |
| BARR PHARMA INC | |
-13.70 | 57.00 |
| ALPHARMA INC |  |
+18.90 | 30.62 |
| WATSON PHARMACE | |
-34.70 | 21.23 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives